Angela G E M de Boer1. 1. Academic Medical Center, Coronel Institute of Occupational Health, PO Box 22700, 1100 DE, Amsterdam, The Netherlands, a.g.deboer@amc.uva.nl.
Abstract
PURPOSE: The number of cancer survivors is rapidly growing due to improved treatment and ageing population. Almost half of cancer patients will experience a cancer diagnosis during working age when career and work-related issues play an important role. Many cancer survivors are at risk for unemployment which greatly affects their quality of life and financial situation. Research on cancer and work is therefore of great importance but scattered over Europe and lacking appropriate dissemination. Moreover, interventions supporting employment of cancer survivors are urgently required but scarcely developed. METHODS: The European Cancer and Work Network (CANWON) aims to combine knowledge on: (1) prognostic factors of unemployment in cancer survivors including gender- and country-specific differences; (2) work-related costs of survivorship for both patients and society; (3) the role of employers; and (4) development and evaluation of innovative, interdisciplinary interventions which effectively support employment. Furthermore, it aims at disseminating research knowledge and best practice worldwide. RESULTS: CANWON currently unites 23 teams from 15 countries across different stakeholders and research areas. The expected benefits are rapid exchange of research knowledge, standardised methods and techniques, innovative interventions, future guidelines on cancer and work and the improvement of quality of life of cancer patients. CONCLUSIONS: Understanding prognostic factors, work-related costs, role of the employer and innovative interventions in relation to work in cancer survivors might progress the understanding of other patients with long-term conditions therefore the knowledge resulting from CANWON will benefit a wide range of patient groups.
PURPOSE: The number of cancer survivors is rapidly growing due to improved treatment and ageing population. Almost half of cancerpatients will experience a cancer diagnosis during working age when career and work-related issues play an important role. Many cancer survivors are at risk for unemployment which greatly affects their quality of life and financial situation. Research on cancer and work is therefore of great importance but scattered over Europe and lacking appropriate dissemination. Moreover, interventions supporting employment of cancer survivors are urgently required but scarcely developed. METHODS: The European Cancer and Work Network (CANWON) aims to combine knowledge on: (1) prognostic factors of unemployment in cancer survivors including gender- and country-specific differences; (2) work-related costs of survivorship for both patients and society; (3) the role of employers; and (4) development and evaluation of innovative, interdisciplinary interventions which effectively support employment. Furthermore, it aims at disseminating research knowledge and best practice worldwide. RESULTS: CANWON currently unites 23 teams from 15 countries across different stakeholders and research areas. The expected benefits are rapid exchange of research knowledge, standardised methods and techniques, innovative interventions, future guidelines on cancer and work and the improvement of quality of life of cancerpatients. CONCLUSIONS: Understanding prognostic factors, work-related costs, role of the employer and innovative interventions in relation to work in cancer survivors might progress the understanding of other patients with long-term conditions therefore the knowledge resulting from CANWON will benefit a wide range of patient groups.
Authors: Sietske J Tamminga; Angela G E M de Boer; Jos H A M Verbeek; Monique H W Frings-Dresen Journal: Scand J Work Environ Health Date: 2011-10-10 Impact factor: 5.024
Authors: Jack B Fu; Melissa P Osborn; Julie K Silver; Benedict S Konzen; An Ngo-Huang; Rajesh Yadav; Eduardo Bruera Journal: Am J Phys Med Rehabil Date: 2017-07 Impact factor: 2.159
Authors: Steffen Torp; Alain Paraponaris; Elke Van Hoof; Marja-Liisa Lindbohm; Sietske J Tamminga; Caroline Alleaume; Nick Van Campenhout; Linda Sharp; Angela G E M de Boer Journal: J Occup Rehabil Date: 2019-06
Authors: Kete M Klaver; Saskia F A Duijts; Chantal A V Geusgens; Maureen J B Aarts; Rudolf W H M Ponds; Allard J van der Beek; Sanne B Schagen Journal: J Cancer Surviv Date: 2022-07-01 Impact factor: 4.442
Authors: Ana F Oliveira; Sofia Fernandes; Juliana D Reis; Ana Torres; Isabel M Santos; Diane Von Ah Journal: BMJ Open Date: 2022-07-12 Impact factor: 3.006
Authors: Angela G E M de Boer; Tyna K Taskila; Sietske J Tamminga; Michael Feuerstein; Monique H W Frings-Dresen; Jos H Verbeek Journal: Cochrane Database Syst Rev Date: 2015-09-25
Authors: Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa Journal: Arch Toxicol Date: 2021-11-02 Impact factor: 5.153
Authors: Larissa Nekhlyudov; Grace B Campbell; Kathryn H Schmitz; Gabriel A Brooks; Anita J Kumar; Patricia A Ganz; Diane Von Ah Journal: Cancer Date: 2021-09-16 Impact factor: 6.921
Authors: Kete M Klaver; Sanne B Schagen; Jacobien M Kieffer; Allard J van der Beek; Saskia F A Duijts Journal: Cancers (Basel) Date: 2021-05-18 Impact factor: 6.639